Literature DB >> 15258311

The role of complement activation in atherosclerosis.

Florin Niculescu1, Horea Rus.   

Abstract

Atherosclerosis is a chronic inflammatory disease in which dyslipidemia, inflammation, and the immune system play an important pathogenetic role. A role in atherogenesis was demonstrated for monocyte/macrophages, complement system, and T-lymphocytes. Complement activation and C5b-9 deposition occurs both in human and experimental atherosclerosis. Complement C6 deficiency has a protective effect on diet-induced atherosclerosis, indicating that C5b-9 assembly is required for the progression of atherosclerotic lesions. The maturation of atherosclerotic lesions beyond the foam cell stage was shown to be strongly dependent on an intact complement system. C5b-9 may be responsible for cell lysis, and sublytic assembly of C5b-9 induces smooth muscle cell (SMC) and endothelial cell (EC) activation and proliferation. All these data suggest that activation of the complement system plays an important role in atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15258311     DOI: 10.1385/IR:30:1:073

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  64 in total

1.  Association between complement factor H and proteoglycans in early human coronary atherosclerotic lesions: implications for local regulation of complement activation.

Authors:  Riina Oksjoki; Hanna Jarva; Petri T Kovanen; Petri Laine; Seppo Meri; Markku O Pentikäinen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-23       Impact factor: 8.311

2.  Complement C5b-9 increases plasminogen binding and activation on human endothelial cells.

Authors:  V J Christiansen; P J Sims; K K Hamilton
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-01       Impact factor: 8.311

3.  Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosis.

Authors:  B P Morgan; J R Dankert; A F Esser
Journal:  J Immunol       Date:  1987-01-01       Impact factor: 5.422

Review 4.  Regulation of differentiation of vascular smooth muscle cells.

Authors:  G K Owens
Journal:  Physiol Rev       Date:  1995-07       Impact factor: 37.312

5.  Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions.

Authors:  P S Seifert; G K Hansson
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

6.  Complement components, but not complement inhibitors, are upregulated in atherosclerotic plaques.

Authors:  K Yasojima; C Schwab; E G McGeer; P L McGeer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-07       Impact factor: 8.311

7.  ApoE(-/-) mice develop atherosclerosis in the absence of complement component C5.

Authors:  S Patel; E M Thelander; M Hernandez; J Montenegro; H Hassing; C Burton; S Mundt; A Hermanowski-Vosatka; S D Wright; Y S Chao; P A Detmers
Journal:  Biochem Biophys Res Commun       Date:  2001-08-10       Impact factor: 3.575

8.  Decay-accelerating factor regulates complement-mediated damage in the human atherosclerotic wall.

Authors:  F Niculescu; H G Rus; R Vlaicu
Journal:  Immunol Lett       Date:  1990-10       Impact factor: 3.685

9.  C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids.

Authors:  Mi-Kyung Chang; Christoph J Binder; Michael Torzewski; Joseph L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-20       Impact factor: 11.205

10.  C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas.

Authors:  G D Reynolds; R P Vance
Journal:  Arch Pathol Lab Med       Date:  1987-03       Impact factor: 5.534

View more
  28 in total

Review 1.  The role of complement system in adipose tissue-related inflammation.

Authors:  Sonia I Vlaicu; Alexandru Tatomir; Dallas Boodhoo; Stefan Vesa; Petru A Mircea; Horea Rus
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

Review 2.  The role of inflammation in the pathogenesis of age-related macular degeneration.

Authors:  Larry A Donoso; David Kim; Arcilee Frost; Alston Callahan; Gregory Hageman
Journal:  Surv Ophthalmol       Date:  2006 Mar-Apr       Impact factor: 6.048

3.  Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.

Authors:  Tomas Vaisar; Subramaniam Pennathur; Pattie S Green; Sina A Gharib; Andrew N Hoofnagle; Marian C Cheung; Jaeman Byun; Simona Vuletic; Sean Kassim; Pragya Singh; Helen Chea; Robert H Knopp; John Brunzell; Randolph Geary; Alan Chait; Xue-Qiao Zhao; Keith Elkon; Santica Marcovina; Paul Ridker; John F Oram; Jay W Heinecke
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

4.  In vivo differences between endothelial transcriptional profiles of coronary and iliac arteries revealed by microarray analysis.

Authors:  Ji Zhang; Kelley A Burridge; Morton H Friedman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-08       Impact factor: 4.733

5.  Spontaneous complement activation on human B cells results in localized membrane depolarization and the clustering of complement receptor type 2 and C3 fragments.

Authors:  Morten Løbner; Robert G Q Leslie; Wolfgang M Prodinger; Claus H Nielsen
Journal:  Immunology       Date:  2009-01-23       Impact factor: 7.397

Review 6.  Complement activation on platelets: implications for vascular inflammation and thrombosis.

Authors:  Ellinor I Peerschke; Wei Yin; Berhane Ghebrehiwet
Journal:  Mol Immunol       Date:  2010-06-01       Impact factor: 4.407

7.  Decay accelerating factor (CD55)-mediated attenuation of complement: therapeutic implications for age-related macular degeneration.

Authors:  Kelly N Ma; Siobhan M Cashman; J Harry Sweigard; Rajendra Kumar-Singh
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-08-04       Impact factor: 4.799

8.  Complement regulator CD59 protects against angiotensin II-induced abdominal aortic aneurysms in mice.

Authors:  Gongxiong Wu; Ting Chen; Aliakbar Shahsafaei; Weiguo Hu; Roderick T Bronson; Guo-Ping Shi; Jose A Halperin; Huseyin Aktas; Xuebin Qin
Journal:  Circulation       Date:  2010-03-08       Impact factor: 29.690

9.  CD59 but not DAF deficiency accelerates atherosclerosis in female ApoE knockout mice.

Authors:  Guipeng An; Takashi Miwa; Wen-Liang Song; John A Lawson; Daniel J Rader; Yun Zhang; Wen-Chao Song
Journal:  Mol Immunol       Date:  2009-03-17       Impact factor: 4.407

10.  Is plasma C3 and C4 levels useful in young cerebral ischemic stroke patients? Associations with prognosis at 3 months.

Authors:  Bin Zhang; Ning Yang; Cong Gao
Journal:  J Thromb Thrombolysis       Date:  2015-02       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.